TickerFacts.

A business in context

IDXX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-20 · 0000874716-26-000125

  2. 8-K · Current report

    Report date 2026-08-04 · 0001104659-26-090033 · Items 2.02,9.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000874716-26-000123

  4. 4 · Ownership change

    Report date 2026-07-30 · 0000874716-26-000117

  5. 4 · Ownership change

    Report date 2026-06-01 · 0000874716-26-000114

  6. 8-K · Current report

    Report date 2026-05-12 · 0000874716-26-000110 · Items 5.03,5.07,9.01

  7. 4 · Ownership change

    Report date 2026-05-12 · 0000874716-26-000107

  8. 4 · Ownership change

    Report date 2026-05-12 · 0000874716-26-000106

  9. 4 · Ownership change

    Report date 2026-05-12 · 0000874716-26-000105

  10. 4 · Ownership change

    Report date 2026-05-12 · 0000874716-26-000104

  11. 4 · Ownership change

    Report date 2026-05-12 · 0000874716-26-000103

  12. 8-K · Current report

    Report date 2026-05-05 · 0001104659-26-055203 · Items 2.02,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000874716-26-000076

  14. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0000874716-26-000064

  15. 8-K · Current report

    Report date 2026-03-24 · 0001104659-26-034906 · Items 5.02,9.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0000874716-26-000038

  17. 8-K · Current report

    Report date 2026-02-13 · 0000874716-26-000007 · Items 5.02

  18. 8-K · Current report

    Report date 2026-02-02 · 0001104659-26-008904 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-11 · 0001104659-26-003103 · Items 5.02,7.01,9.01

  20. 8-K · Current report

    Report date 2025-11-12 · 0001104659-25-111278 · Items 1.01,2.03,9.01

  21. 8-K · Current report

    Report date 2025-11-03 · 0001104659-25-105185 · Items 2.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000874716-25-000165

  23. 8-K · Current report

    Report date 2025-10-06 · 0001104659-25-097319 · Items 5.02,9.01

  24. 8-K · Current report

    Report date 2025-08-04 · 0001104659-25-073304 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000874716-25-000121

  26. 8-K · Current report

    Report date 2025-07-10 · 0001104659-25-066840 · Items 5.02,9.01

  27. 8-K · Current report

    Report date 2025-05-07 · 0000874716-25-000085 · Items 5.03,5.07,9.01

  28. 8-K · Current report

    Report date 2025-05-01 · 0001104659-25-042955 · Items 2.02,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000874716-25-000062

  30. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0000874716-25-000054

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000874716-25-000037

  32. 8-K · Current report

    Report date 2025-02-13 · 0000874716-25-000011 · Items 5.02

  33. 8-K · Current report

    Report date 2025-02-03 · 0001104659-25-008331 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2024-12-06 · 0000874716-24-000150 · Items 5.02

  35. 8-K · Current report

    Report date 2024-12-03 · 0000874716-24-000148 · Items 8.01,9.01

  36. 8-K · Current report

    Report date 2024-11-20 · 0001104659-24-121326 · Items 5.02,7.01,9.01

  37. 8-K · Current report

    Report date 2024-11-08 · 0001104659-24-116365 · Items 5.02,9.01

  38. SC 13G/A · Ownership disclosure

    0000932471-24-001019

  39. 8-K · Current report

    Report date 2024-10-31 · 0000874716-24-000142 · Items 1.01

  40. SC 13G/A · Ownership disclosure

    0000932471-24-000416

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 21 transaction rows21AExercise / conversion: 16 transaction rows16MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

38 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-01
2026-06-02
FENNELL GEORGEF · Tax / exercise payment
Disposed
Common Stock284.0566.79
2026-06-01
2026-06-02
FENNELL GEORGEM · Exercise / conversion
Acquired
Common Stock639.00.0
2026-06-01
2026-06-02
FENNELL GEORGEM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
639.0—
2026-05-12
2026-05-14
Vandebroek Sophie V.A · Grant / award
Acquired
Restricted Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
Vandebroek Sophie V.A · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-12
2026-05-14
SAMAD SAMA · Grant / award
Acquired
Deferred Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
SAMAD SAMA · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-12
2026-05-14
Peacock KarenA · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-12
2026-05-14
Peacock KarenA · Grant / award
Acquired
Deferred Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
Kingsley Lawrence DA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
75.00.0
2026-05-12
2026-05-14
Kingsley Lawrence DA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
Kingsley Lawrence DA · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
168.00.0
2026-05-12
2026-05-14
Kingsley Lawrence DA · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-12
2026-05-14
JUNIUS DANIEL MA · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-12
2026-05-14
JUNIUS DANIEL MA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
HOOLEY JOSEPH LA · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-12
2026-05-14
HOOLEY JOSEPH LA · Grant / award
Acquired
Deferred Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
ESSIG STUARTA · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-12
2026-05-14
ESSIG STUARTA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
Claflin Bruce L.A · Grant / award
Acquired
Deferred Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
Claflin Bruce L.A · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-12
2026-05-14
Britt Irene ChangA · Grant / award
Acquired
Deferred Stock Unit
Derivative security
234.00.0
2026-05-12
2026-05-14
Britt Irene ChangA · Grant / award
Acquired
Non-Qualified Stock Option (right-to-buy)
Derivative security
525.00.0
2026-05-07
2026-05-11
Vandebroek Sophie V.M · Exercise / conversion
Acquired
Common Stock257.00.0
2026-05-07
2026-05-11
Vandebroek Sophie V.M · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
257.0—
2026-05-07
2026-05-11
SZOSTAK M ANNEM · Exercise / conversion
Acquired
Common Stock257.00.0
2026-05-07
2026-05-11
SZOSTAK M ANNEM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
257.0—
2026-05-07
2026-05-11
Peacock KarenM · Exercise / conversion
Acquired
Common Stock101.00.0
2026-05-07
2026-05-11
Peacock KarenM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
101.0—
2026-05-07
2026-05-11
Kingsley Lawrence DM · Exercise / conversion
Acquired
Common Stock257.00.0
2026-05-07
2026-05-11
Kingsley Lawrence DM · Exercise / conversion
Acquired
Common Stock82.00.0
2026-05-07
2026-05-11
Kingsley Lawrence DM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
257.0—
2026-05-07
2026-05-11
Kingsley Lawrence DM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
82.0—
2026-05-07
2026-05-11
JUNIUS DANIEL MM · Exercise / conversion
Acquired
Common Stock257.00.0
2026-05-07
2026-05-11
JUNIUS DANIEL MM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
257.0—
2026-05-07
2026-05-11
HOOLEY JOSEPH LM · Exercise / conversion
Acquired
Common Stock158.00.0
2026-05-07
2026-05-11
HOOLEY JOSEPH LM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
158.0—
2026-04-30
2026-05-04
HOOLEY JOSEPH LA · Grant / award
Acquired
Common Stock43.0560.8

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000874716IDEXX LABORATORIES INC /DE
IDEXX Laboratories (France)

Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
OGMTXK0LUU1HKV2P0J84
GLEIF legal name
IDEXX LABORATORIES, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-04-11T18:30:50Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • IDEXX Laboratories, Inc. · alias · wikidata
  • Idexx Laboratories · alias · wikidata
  • IDEXX Laboratories (France) · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$3.90B$4.15B
2023-12-31$3.66B$4.01B
2022-12-31$3.37B$3.84B
2021-12-31$3.22B$3.96B
2020-12-31$2.71B$3.49B
2019-12-31$2.41B$3.14B
2018-12-31$2.21B$2.94B
2017-12-31$1.97B$2.68B

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗